The novel treatment of the medication represents a major development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatide-peptide670301.blogolenta.com/39079792/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment